Leadership changes at Soliant Health bring Graig Paglieri to CEO role.

  • Graig Paglieri takes on role of CEO at Soliant Health.
  • David Alexander steps down as CEO to become Vice Chairman.
  • Leadership changes aim to enhance healthcare staffing services.

Soliant Health has announced the appointment of Graig Paglieri as its new CEO, marking a significant leadership transition within the healthcare staffing company. David Alexander, the company's founder, will step into the role of Vice Chairman, allowing him to continue contributing to the organization while handing over daily operational responsibilities. This change aims to position Soliant Health for future growth and success in the evolving healthcare landscape.

Paglieri has a robust background in healthcare staffing and has been with Soliant for several years, most recently serving as the Chief Operating Officer. His experience is expected to strengthen the company's focus on delivering high-quality healthcare professionals to facilities nationwide. As Vice Chairman, Alexander will shift his focus to strategic initiatives and long-term goals for the organization.

The leadership transition reflects Soliant Health's commitment to adapting to the needs of healthcare providers and professionals. With Paglieri at the helm, the company intends to enhance its service offerings and maintain a high standard of excellence in healthcare staffing.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

HelpMeSee Unveils Next-Generation MSICS Training System at SAFO

New training system aims to improve global solutions for blindness. HelpMeSee launches…

Volta Labs and Watchmaker Genomics Partner for DNA Library Prep Kit

New Callisto Complete Kit simplifies DNA library preparation for researchers. Volta Labs…

Services PMI at 53.8 in January 2026, According to ISM Report

January sees strong growth in services sector as PMI remains robust. Services…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…